90 related articles for article (PubMed ID: 1266642)
1. [Synthesis of new 7, 8 and 9-membered heterocyclic compounds containing oxygen and nitrogen as heteroatoms. III. Synthesis of new hexahydro-1,5-oxazocine derivatives with potential pharmacological activity].
Glinka R; Kotelko B
Acta Pol Pharm; 1976; 33(1):39-48. PubMed ID: 1266642
[No Abstract] [Full Text] [Related]
2. [Synthesis of new 7-, 8- and 9-membered heterocyclic compounds containing oxygen and nitrogen as heteroatoms. II. Synthesis of hexahydro-1,4,5-oxadiazocine].
Glinka R; Kotelko B
Acta Pol Pharm; 1975; 32(6):667-72. PubMed ID: 1211207
[No Abstract] [Full Text] [Related]
3. [Synthesis of new 7-, 8- and 9-membered heterocyclic compounds with oxygen and nitrogen as heteroatoms. I. Synthesis of new derivatives of hexahydro-1,4,5-oxadiazepine].
Glinka R; Kotelko B
Acta Pol Pharm; 1975; 32(5):525-32. PubMed ID: 1199753
[No Abstract] [Full Text] [Related]
4. Investigations of anthelminthic activity and synthesis of new derivatives of perhydroazepine, perhydro-1,4-diazepine, perhydro-1,4-oxazepine and perhydro-1,5-oxazocine.
Glinka R; Grzywacz M; Kotełko B; Majchrzak M; Malinowski H; Mikołajewska H; Mikiciukolasik E; Szkukliński J
Pol J Pharmacol Pharm; 1980; 32(5):773-7. PubMed ID: 7196575
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antimicrobial activities of oxazepine and oxazocine derivatives.
Tang J; Jiang YL; Wang BX; Shen YM
Z Naturforsch C J Biosci; 2014; 69(7-8):283-90. PubMed ID: 25265848
[TBL] [Abstract][Full Text] [Related]
6. [Synthesis and the effect of new derivatives of perhydro-1,4,6-oxadiazocine on the central nervous system].
Brzezińska E; Glinka R; Szadowska A; Kiełek MB
Acta Pol Pharm; 1988; 45(5):400-5. PubMed ID: 2907843
[No Abstract] [Full Text] [Related]
7. Facile synthesis of tetracyclic azepine and oxazocine derivatives and their potential as MAPKAP-K2 (MK2) inhibitors.
Rao AU; Xiao D; Huang X; Zhou W; Fossetta J; Lundell D; Tian F; Trivedi P; Aslanian R; Palani A
Bioorg Med Chem Lett; 2012 Jan; 22(2):1068-72. PubMed ID: 22182499
[TBL] [Abstract][Full Text] [Related]
8. 2-substituted-4-aryl-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,5]oxazocin-5-one as a structurally new NK1 antagonist.
Seto S; Tanioka A; Ikeda M; Izawa S
Bioorg Med Chem Lett; 2005 Mar; 15(5):1485-8. PubMed ID: 15713412
[TBL] [Abstract][Full Text] [Related]
9. [Synthesis of derivatives of perhydroazepine, perhydro-1,5-oxazocine, morpholine and piperazine containing 3-(isopropylamino)-propan-2-ol group--compounds with potential effect on the circulatory system and central nervous system].
Kotełko B; Mikołajewska H; Glinka R; Guryn R
Acta Pol Pharm; 1985; 42(5):433-6. PubMed ID: 3834763
[No Abstract] [Full Text] [Related]
10. [Synthesis of hexahydro-1,4-diazepine derivatives with potential pharmacological effects. IV. Synthesis and studies on the antihistaminic activity of hexahydro-1,4-diazepine derivatives containing ether groups].
Guryn R; Kotełko A; Majchrzak M; Szadowska A; Wejman I
Acta Pol Pharm; 1980; 37(1):53-8. PubMed ID: 6104893
[No Abstract] [Full Text] [Related]
11. Design and synthesis of novel 9-substituted-7-aryl-3,4,5,6-tetrahydro-2H-pyrido[4,3-b]- and [2,3-b]-1,5-oxazocin-6-ones as NK(1) antagonists.
Seto S; Tanioka A; Ikeda M; Izawa S
Bioorg Med Chem Lett; 2005 Mar; 15(5):1479-84. PubMed ID: 15713411
[TBL] [Abstract][Full Text] [Related]
12. Naphtho[2,1-b][1,5] and [1,2-f][1,4]oxazocines as selective NK1 antagonists.
Ohnmacht CJ; Albert JS; Bernstein PR; Rumsey WL; Masek BB; Dembofsky BT; Koether GM; Andisik DW; Aharony D
Bioorg Med Chem; 2004 May; 12(10):2653-69. PubMed ID: 15110847
[TBL] [Abstract][Full Text] [Related]
13. [New derivatives of 7- and 8-member perhydrocyclic compounds. II. Studies on the effect on the central nervous system and circulatory system of new derivatives of perhydro-1,4-oxazepine, perhydro-1,4-diazepine, perhydro-1,4,5-oxadiazepine and perhydro-1,5-oxazocine containing the 2-guanidinoethyl group].
Szadowska A; Działek S; Kiełek MB; Kusowska J; Wejman I
Acta Pol Pharm; 1985; 42(1):55-60. PubMed ID: 4040312
[No Abstract] [Full Text] [Related]
14. Design, synthesis, and evaluation of novel 2-substituted-4-aryl-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,5]oxazocin-5-ones as NK1 antagonists.
Seto S; Tanioka A; Ikeda M; Izawa S
Bioorg Med Chem; 2005 Oct; 13(20):5717-32. PubMed ID: 15993086
[TBL] [Abstract][Full Text] [Related]
15. The newly synthetized pyridobenzoxazocynone inhibits HIV-1 reverse transcriptase activity.
Nowak D; Glinka R; Pietras T; Cieslinski M; Mazerant P; Idowski P; Leder M; Sidorkiewicz M
Farmaco; 1997 Dec; 52(12):751-3. PubMed ID: 9648281
[TBL] [Abstract][Full Text] [Related]
16. New derivatives of hexahydroazepine, hexahydro(1,4,5)oxadiazepine and hexahydro(1,4,5)oxadiazocine with expected pharmacological activity.
Glinka R; Kotełko B; Mikołajewska H; Mikiciuk-Olasik E
Pol J Pharmacol Pharm; 1979; 31(1):65-71. PubMed ID: 482167
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of hexahydro-1,4-oxazepine derivatives with expected pharmacological activity. VI. -Homomorpholinoethyl and -morpholinoethyl phenoxy- and halophenoxyacetates.
Kotelko B; Rokita T
Acta Pol Pharm; 1972; 29(4):365-71. PubMed ID: 4652506
[No Abstract] [Full Text] [Related]
18. [Synthesis of hexahydrodiazepine-1,4 with potential pharmacological activity. III. Synthesis of hexahydrodiazepine-1,4 derivatives containing amide groups with potential pharmacological activity].
Guryn R; Kotelko A; Majchrzak M
Acta Pol Pharm; 1975; 32(5):533-7. PubMed ID: 1199754
[No Abstract] [Full Text] [Related]
19. Structure-activity relationship of new 10-13 membered oxygen-nitrogen heterocyclic systems containing two aromatic rings.
Walczyński K; Glinka R; Stepień A; Olszak T; Sabatino P
Pharmazie; 1992 Jun; 47(6):409-11. PubMed ID: 1357679
[TBL] [Abstract][Full Text] [Related]
20. [Heterocyclic amine derivatives - analogs of mebanazine, pheniprazine and phenelzine. II. Studies on the effect, on the central nervous system, of derivatives of perhydroazepine, perhydro-1,4-diazepine, perhydro-1,4-oxazepine, perhydro-1,5-oxazocine and morpholine-containing arylalkyloamine groups].
Szadowska A; Mazur M; Szmigielski A; Szmigielska H; Winer A
Acta Pol Pharm; 1983; 40(1):111-8. PubMed ID: 6136156
[No Abstract] [Full Text] [Related]
[Next] [New Search]
